
From Trials to Practice: What's New and What's Next for Myeloma
Drs. Gurbakhash Kaur and Danai Dima discuss next-gen CAR T and bispecific therapies for myeloma, including agents for extramedullary disease and GPRC5D targets.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.